VINCENT MED (01612) Schedules 25 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal

Bulletin Express

Mar 10

Vincent Medical Holdings Limited has announced that its board of directors will convene on 25 March 2026. The agenda includes:

• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.

• Authorising the publication of the FY 2025 results announcement.

• Considering the declaration of a final dividend, if any.

The meeting will be chaired by Mr. Choi Man Shing, who serves as Chairman and Executive Director. As of the announcement date, the board comprises four executive directors (Mr. Choi Man Shing, Mr. Choi Cheung Tai Raymond, Mr. Koh Ming Fai, and Mr. Fu Kwok Fu), one non-executive director (Dr. Leung Ming Chu) and three independent non-executive directors (Mr. Mok Kwok Cheung Rupert, Mr. Au Yu Chiu Steven, and Prof. Yung Kai Leung).

The disclosure was released in Hong Kong on 10 March 2026. No further financial metrics were provided in the announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1147735683"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1147735683\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1147735683?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 16:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147735683","market":"hk","top_or_hot":-1,"title":"VINCENT MED (01612) Schedules 25 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal","media":"Bulletin Express","content":"<p>Vincent Medical Holdings Limited has announced that its board of directors will convene on 25 March 2026. The agenda includes:</p>\n<p>• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.</p>\n<p>• Authorising the publication of the FY 2025 results announcement.</p>\n<p>• Considering the declaration of a final dividend, if any.</p>\n<p>The meeting will be chaired by Mr. Choi Man Shing, who serves as Chairman and Executive Director. As of the announcement date, the board comprises four executive directors (Mr. Choi Man Shing, Mr. Choi Cheung Tai Raymond, Mr. Koh Ming Fai, and Mr. Fu Kwok Fu), one non-executive director (Dr. Leung Ming Chu) and three independent non-executive directors (Mr. Mok Kwok Cheung Rupert, Mr. Au Yu Chiu Steven, and Prof. Yung Kai Leung).</p>\n<p>The disclosure was released in Hong Kong on 10 March 2026. No further financial metrics were provided in the announcement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>VINCENT MED (01612) Schedules 25 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVINCENT MED (01612) Schedules 25 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-10 16:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vincent Medical Holdings Limited has announced that its board of directors will convene on 25 March 2026. The agenda includes:</p>\n<p>• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.</p>\n<p>• Authorising the publication of the FY 2025 results announcement.</p>\n<p>• Considering the declaration of a final dividend, if any.</p>\n<p>The meeting will be chaired by Mr. Choi Man Shing, who serves as Chairman and Executive Director. As of the announcement date, the board comprises four executive directors (Mr. Choi Man Shing, Mr. Choi Cheung Tai Raymond, Mr. Koh Ming Fai, and Mr. Fu Kwok Fu), one non-executive director (Dr. Leung Ming Chu) and three independent non-executive directors (Mr. Mok Kwok Cheung Rupert, Mr. Au Yu Chiu Steven, and Prof. Yung Kai Leung).</p>\n<p>The disclosure was released in Hong Kong on 10 March 2026. No further financial metrics were provided in the announcement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01612","symbol_name":"永胜医疗","start_time":0,"source_url":"","article_id":"1147735683","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147735683","pubTimestamp":1773132175,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Vincent Medical Holdings Limited has announced that its board of directors will convene on 25 March 2026. The agenda includes: • Reviewing and approving the consolidated annual results for the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01612":"永胜医疗"},"translate_title":"VINCENT MED(01612)定于2026年3月25日召开董事会批准2025财年业绩和末期股息建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01612":1},"content_text":"Vincent Medical Holdings Limited has announced that its board of directors will convene on 25 March 2026. The agenda includes:\n• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.\n• Authorising the publication of the FY 2025 results announcement.\n• Considering the declaration of a final dividend, if any.\nThe meeting will be chaired by Mr. Choi Man Shing, who serves as Chairman and Executive Director. As of the announcement date, the board comprises four executive directors (Mr. Choi Man Shing, Mr. Choi Cheung Tai Raymond, Mr. Koh Ming Fai, and Mr. Fu Kwok Fu), one non-executive director (Dr. Leung Ming Chu) and three independent non-executive directors (Mr. Mok Kwok Cheung Rupert, Mr. Au Yu Chiu Steven, and Prof. Yung Kai Leung).\nThe disclosure was released in Hong Kong on 10 March 2026. No further financial metrics were provided in the announcement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}